Press Releases by "Otsuka Pharmaceutical Co., Ltd."

• Otsuka’s Novel Treatment for Multidrug-Resistant Tuberculosis, Delamanid, Filed in Japan After Half-A-Century Since Last Drug Approval for Tuberculosis
  [ Pharmaceuticals | 2013-03-27]
• Lundbeck and Otsuka Further Expand Alliance and Enter Into Collaboration For the Development and Commercialization of Lu AE58054 In Development For Alzheimer’s Disease
  [ Pharmaceuticals | 2013-03-26]
• Otsuka Obtains Marketing Approval in Japan for OnglyzaⓇ Tablets to Treat Type 2 Diabetes; Transferred Rights to Kyowa Hakko Kirin
  [ Pharmaceuticals | 2013-03-25]
• “Weight Management with Chocolate”, White Chocolate and Orange Chocolate, Gerlinéa Meal Replacement Bars Debut on March 18
  [ Pharmaceuticals | 2013-03-14]
• “Weight Management with Chocolate” White Chocolate and Orange Chocolate Gerlinéa Meal Replacement Bars Debut on March 18
  [ Pharmaceuticals | 2013-03-14]
• The healthy benefits of whole soy flavored with crunchy peanuts, SOYJOY Peanuts Debuts April 24
  [ Pharmaceuticals | 2013-03-13]
• The healthy benefits of whole soy flavored with crunchy peanuts SOYJOY Peanuts Debuts April 24
  [ Pharmaceuticals | 2013-03-13]
• Otsuka Advancing Rapidly in Central Nervous System Disorders; Expanding Its Existing Collaboration with Lundbeck
  [ Pharmaceuticals | 2013-03-07]
• The First Transdermal Dopamin Agonist in Japan Neupro® Patch, For Both Parkinson’s Disease and Restless Legs Syndrome, To Be Launched on February 26
  [ Pharmaceuticals | 2013-02-22]
• L-Cartin® FF oral solution 10% and L-Cartin® FF injection 1000mg Two New Drug Forms for Carnitine Deficiency To Be Launched on February 26
  [ Pharmaceuticals | 2013-02-22]
• Otsuka Pharmaceutical Contributes to the Success and Development of the Tokyo Marathon as a Total Health Care Company Supporting Safe Running and Encouraging Runners to Complete the Full Distance with Amino Acids, Fluids and Electrolytes
  [ Pharmaceuticals | 2013-02-20]
• 7.5mg Tablets Additionally Approved - Samsca®, Vasopressin V2 Receptor Antagonist
  [ Pharmaceuticals | 2013-02-08]
• The European Medicines Agency (EMA) Approves Aripiprazole (ABILIFY®) for the Treatment of Moderate to Severe Manic Episodes in Bipolar I Disorder in Adolescents.
  [ Pharmaceuticals | 2013-02-06]
• FDA Approves Once-Monthly ABILIFY MAINTENA™ (Aripiprazole) For Extended-Release Injectable Suspension for the Treatment of Schizophrenia
  [ Pharmaceuticals | 2013-02-01]
• UL・OS Line of Men’s Skincare Launches New SPF 50 & SPF 25 Sunscreens Applies Smoothly, Leaves No White Residue
  [ Pharmaceuticals | 2013-01-28]
• Otsuka Pharmaceutical Files for Application of New Dry Powder Inhaler Product from the Meptin Brand
  [ Pharmaceuticals | 2013-01-11]
• French subsidiary Nutrition & Santé acquires gluten-free nutrition company from Lactalis Group
  [ Pharmaceuticals | 2013-01-09]
• Otsuka and Lundbeck initiate the regulatory process for aripiprazole (once-monthly) depot formulation in Europe
  [ Pharmaceuticals | 2012-12-25]
• L-Cartin® FF oral solution 10% and L-Cartin® FF injection 1000mg Two New Drug Forms approved for Carnitine Deficiency
  [ Pharmaceuticals | 2012-12-25]
• The World’s Only Transdermal Dopamin Agonist, Neupro® Patch, Approved in Japan for Both Parkinson’s Disease and Restless Legs Syndrome
  [ Pharmaceuticals | 2012-12-25]

Most Popular: "Otsuka Pharmaceutical Co., Ltd."